Ikarian Capital, LLC Corcept Therapeutics Inc Call Options Transaction History

Ikarian Capital, LLC

  • $247 Million
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$22.21 - $34.48 $6.17 Million - $9.57 Million
-277,640 Reduced 99.33%
1,860 $60,000
Q1 2024

May 15, 2024
BUY
$21.1 - $27.46 $173,020 - $225,172
8,200 Added 3.02%
279,500 $7.04 Million
Q4 2023

Feb 14, 2024
BUY
$24.82 - $32.88 $6.73 Million - $8.92 Million
271,300 New
271,300 $8.81 Million

Others Institutions Holding CORT

# of Institutions
311
Shares Held
88.3M
Call Options Held
1.07M
Put Options Held
973K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.71B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email